Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring
about
Medication use and the risk of motor vehicle collisions among licensed drivers: A systematic review.A randomized, crossover, placebo-controlled clinical trial to assess the sensitivity of the CRCDS Mini-Sim to the next-day residual effects of zopicloneResidual effects of zopiclone 7.5 mg on highway driving performance in insomnia patients and healthy controls: a placebo controlled crossover study.Impaired driving performance associated with effect of time duration in patients with primary insomnia.British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders.[The newer sedative-hypnotics].Zolpidem ingestion, automatisms, and sleep driving: a clinical and legal case seriesBehavioral and Neurophysiological Signatures of Benzodiazepine-Related Driving ImpairmentsEmerging pharmacotherapeutic agents for insomnia: a hypnotic panacea?Postoperative use of hypnotics is associated with increased length of stay after uncomplicated surgery for colorectal cancer.Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics.Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence.A new sublingual formulation of zolpidem for the treatment of sleep-onset insomnia.Zolpidem for insomnia.Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.Management of insomnia in elderly patients using eszopiclone.Insomnia and accidents: cross-sectional study (EQUINOX) on sleep-related home, work and car accidents in 5293 subjects with insomnia from 10 countries.The effects of acute treatment with ramelteon, triazolam, and placebo on driving performance, cognitive function, and equilibrium function in healthy volunteers.Sleep-promoting medications: Weighing the hazards of use versus non-use.Pharmacokinetic evaluation of eszopiclone: clinical and therapeutic implications.
P2860
Q30248258-6F43B525-2ED7-4321-9497-C1AF0329B95AQ30659467-8490ABA4-364C-4B6F-903F-89C4A3D8DA1AQ33810623-909715EB-6F36-4DAF-BD3B-6268B595249FQ34125888-07777BB9-81DF-4045-88B2-AF1F11BADCEAQ34135759-BB4A1B3A-DCED-4AF7-B5B0-6D564DACE0B6Q34143490-9173BBFD-B7CE-4B00-B0C5-52131F180D34Q35583074-4539150E-A3C9-4DD3-83AD-CC6E4ADFE675Q36320094-120D5AA0-8FCB-4930-9CC0-703C9B41722AQ36573888-A7C5C2D3-C9ED-4778-B0B2-84B66B6677D7Q37241850-8258E078-C918-47BA-8A4F-238003D0AF03Q37639811-800C03B5-7943-4204-88A7-1E3E28D051D7Q37830027-00F20A1F-E39C-4FCE-A55A-6B80CB5D33ABQ37979871-0017AF38-4930-4FA7-B38A-FC62072533BFQ37994346-884AF095-E7E2-47B2-9790-5C0DD0593ED2Q39044821-296A5053-55E3-4E77-995E-03C52D9C0FF9Q39960467-C49833ED-3120-4964-B302-65004B875135Q40150808-59CAF82E-5E07-458D-9D8E-8231694FBF61Q48006027-BFEBBF3C-3CF5-4C41-95B8-7F27C61ECA0AQ48110300-6D9F809B-1A49-4B28-8BD2-B0C9FA7DCCCDQ48214279-FF73DAB6-3F7E-4597-B55E-E4A664EC7BCC
P2860
Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Next-day residual effects of h ...... lectroencephalogram monitoring
@ast
Next-day residual effects of h ...... lectroencephalogram monitoring
@en
Next-day residual effects of h ...... lectroencephalogram monitoring
@nl
type
label
Next-day residual effects of h ...... lectroencephalogram monitoring
@ast
Next-day residual effects of h ...... lectroencephalogram monitoring
@en
Next-day residual effects of h ...... lectroencephalogram monitoring
@nl
prefLabel
Next-day residual effects of h ...... lectroencephalogram monitoring
@ast
Next-day residual effects of h ...... lectroencephalogram monitoring
@en
Next-day residual effects of h ...... lectroencephalogram monitoring
@nl
P2093
P2860
P3181
P1433
P1476
Next-day residual effects of h ...... lectroencephalogram monitoring
@en
P2093
Alain Muzet
Gilbert Rinaudo
Luc Staner
Marie Agnès Arnal
Peter Boeijinga
Rémy Luthringer
Stéphane Ertlé
P2860
P2888
P3181
P356
10.1007/S00213-005-0082-8
P407
P577
2005-10-01T00:00:00Z
P5875
P6179
1042340115